The lipid peroxidation products as possible markers of Alzheimer's disease in blood

Experimental Gerontology

Volumn 46, Issue 1, 2011, Pages 38-42

  Skoumalova A ^a   Ivica, J ^a   Santorova P ^a   Topinkova E ^a   Wilhelm, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Alzheimer's disease; Diagnostic biomarkers; Lipofuscin like pigments; Oxidative stress

Indexed keywords

FREE RADICAL; LIPOFUSCIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE LEVEL; FEMALE; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; FEMALE; HUMANS; LIPID PEROXIDATION; LIPOFUSCIN; MALE; OXIDATIVE STRESS; SPECTROMETRY, FLUORESCENCE;

EID: 78649817567     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.09.015     Document Type: Article

References (22)

1. Bermejo P., Martín-Aragón S., Benedí J., Susín C., Felici E., Gil P., Ribera J.M., Villar Á.M. Peripheral levels of Alzheimer's disease from mild cognitive impairment. Free Radic. Res. 2008, 42:162-170.
2. Bourdel-Marchasson I., Delmas-Beauvieux M.-C., Peuchant E., Richard-Harston S., Decamps A., Reignier B., Emeriau J.-P., Rainfray M. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001, 30:235-241.
3. Chio K.S., Tappel A.L. Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 1969, 8:2821-2826.
4. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
5. Goldstein B.D., McDonagh E.M. Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone. J. Clin. Invest. 1976, 57:1302-1307.
6. Greilberger J., Koidl C., Greilberger M., Lamprecht M., Schroecknadel K., Leblhuber F., Fuchs D., Oettl K. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic. Res. 2008, 42:633-638.
7. Gustaw-Rothenberg K., Lerner A., Bonda D.J., Lee H.G., Zhu X., Perry G., Smith M.A. Biomarkers in Alzheimer's disease: past, present and future. Biomark. Med. 2010, 4(1):15-26.
8. Markesbery W.R., Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol. 1999, 9:133-146.
9. McGrath L.T., McGleenon B.M., Brennan S., McColl D., McIlroy S., Passmore A.P. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. Q. J. Med. 2001, 94:485-490.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
11. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J., Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 2002, 33:620-626.
12. Praticò D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy. Ann. NY Acad. Sci. 2008, 1147:70-78.
13. Praticò D., Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am. J. Med. 2000, 109:577-585.
14. Praticò D., Lee V.M.-Y., Trojanowski J.Q., Rokach J., Fitzgerald G.A. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 1998, 12:1777-1783.
15. Roman, et al. Vascular dementia: diagnostic criteria for research studies. Neurology 1993, 43:250-260.
16. Shah R.S., Lee H.-G., Xiongwei Z., Perry G., Smith M.A., Castellani R.J. Current approaches in the treatment of Alzheimer's disease. Biomed. Pharmacother. 2008, 62:199-207.
17. Skoumalova A., Rofina J., Schwippelová Z., Gruys E., Wilhelm J. The role of free radicals in canine counterpart of senile dementi of the Alzheimer type. Exp. Gerontol. 2003, 38:711-719.
18. Strafacea E., Matarresea P., Gambardellaa L., Vonaa R., Sgadarib A., Silverib M.C., Malorni W. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett. 2005, 579:2759-2766.
19. Vasankari T., Kujala U., Heinonen O., Kapanen J., Ahotupa M. Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. Clin. Chim. Acta 1995, 31:63-69.
20. Vesela A., Wilhelm J., Kawaciuk I. Investigation of the role of free radical damage in patients after transurethral prostatectomy. J. Urol. 2002, 167:221-222.
21. Wihlmark U., Wrigstad A., Roberg K., Brunk U.T., Nilsson S.E. Formation of lipofuscin in cultured retinal pigment epithelial cells exposed to pre-oxidized photoreceptor outer segments. APMIS 1996, 104:272-279.
22. Wilhelm J., Herget J. Hypoxia induces free radical damage to rat erythrocytes and spleen: analysis of the fluorescent end-products of lipid peroxidation. IJBCB 1999, 31:671-681.